Evidence map›Paper›PMID 40087981›Full record

ArticleThe international journal of neuropsychopharmacology2025

Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach.

Sou Sugiki, Shigeki Tsuchiya, Ren Kimura, Shun Katada, Koichi Misawa, Hisashi Tsujimura, Masanobu Hibi

Abstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sou SugikiHuman Health Care Products Research, Kao Corporation, Tokyo, Japan.ORCID 0009-0008-6167-0362
Shigeki TsuchiyaAnalytical Science Research, Kao Corporation, Tokyo, Japan.ORCID 0000-0002-7481-0941
Ren KimuraAnalytical Science Research, Kao Corporation, Tokyo, Japan.
Shun KatadaHuman Health Care Products Research, Kao Corporation, Tokyo, Japan.
Koichi MisawaHuman Health Care Products Research, Kao Corporation, Tokyo, Japan.
Hisashi TsujimuraAnalytical Science Research, Kao Corporation, Tokyo, Japan.
Masanobu HibiHuman Health Care Products Research, Kao Corporation, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global prevalence of dementia is significantly increasing. Early detection and prevention strategies, particularly for mild cognitive impairment (MCI), are crucial but currently hindered by the lack of established biomarkers. Here, we aimed to develop a high-precision screening method for MCI by combining D-amino acid profiles from peripheral blood samples with noninvasive subject information using nonlinear machine learning (ML) algorithms.

methodsA cross-sectional study was conducted with 200 participants aged 50-89 years, classified into cognitively normal and MCI-suspected groups based on Mini-Mental State Examination scores. High-throughput techniques were used to analyze the D-amino acid profiles, specifically D-alanine (%) and D-proline (%), in peripheral blood. Correlation analysis was performed between D-amino acid levels in venous and fingertip blood. The predictive performance of various ML models, including Logistic Regression, Random Forest, kernel Support Vector Machine (SVM), and Artificial Neural Network (ANN), was compared.

resultsNonlinear models (kernel SVM and ANN) that combined D-amino acid profiles with subject information achieved the highest area under the curve values of 0.78 and 0.79, respectively, demonstrating that the combination of D-amino acid profiles and noninvasive subject information is effective in detecting MCI.

conclusionsCombining D-amino acid profiles with noninvasive subject information using nonlinear ML models, particularly kernel SVM and ANN, shows promise as a high-precision screening tool for MCI. This approach could serve as a cost-effective preliminary screening method before more invasive and expensive diagnostic tests and significantly contribute to the early detection and development of intervention strategies for dementia.

Indexed as

AlanineCognitive DysfunctionMachine LearningProlineAgedAged, 80 and overBiomarkersCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeural Networks, ComputerSupport Vector MachineAlanineBiomarkersProlineD-amino acidsdementiaearly detectionmachine learningmild cognitive impairmentnonlinear modelsperipheral bloodscreening tool

Identifiers

PMID40087981
PMCPMC12012366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.